Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Atlas Venture Fund IX, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
01/31/2023 SC 13G/A Atlas Venture Fund IX, L.P. reports a 4.9% stake in sURFACE ONCOLOGY, Inc.
01/25/2022 SC 13G/A Atlas Venture Fund IX, L.P. reports a 2.3% stake in COGENT BIOSCIENCES
01/25/2022 SC 13G/A Atlas Venture Fund IX, L.P. reports a 6.4% stake in sURFACE ONCOLOGY, Inc.
01/25/2022 SC 13G/A Atlas Venture Fund IX, L.P. reports a 4.3% stake in spero therapeutics, Inc.
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2021 SC 13G/A Atlas Venture Fund IX, L.P. reports a 8.1% stake in COGENT BIOSCIENCES
12/28/2020 SC 13D Atlas Venture Fund IX, L.P. reports a 8% stake in Skillz Inc.
12/21/2020 4/A Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.
Txns: Sold 1,700,000 shares @ $8.1, valued at $13.8M
12/21/2020 4 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.
Txns: Sold 1,700,000 shares @ $18.1, valued at $30.8M
02/04/2020 SC 13G/A Atlas Venture Fund IX, L.P. reports a 11% stake in UNUM THERAPEUTICS, Inc.
02/04/2020 SC 13G/A Atlas Venture Fund IX, L.P. reports a 16.7% stake in sURFACE ONCOLOGY, Inc.
02/04/2020 SC 13G/A Atlas Venture Fund IX, L.P. reports a 7.2% stake in SPERO THERAPEUTICS, Inc.
02/08/2019 SC 13G Atlas Venture Fund IX, L.P. reports a 11.2% stake in UNUM THERAPEUTICS, INC.
02/08/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2019 SC 13G/A Atlas Venture Fund IX, L.P. reports a 7.6% stake in SPERO THERAPEUTICS, INC.
04/23/2018 4 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.
Txns: Converted 3,181,817 shares @ $0
Bought 100,000 shares @ $15, valued at $1.5M
Converted 7,000,000 preferred shares @ $0
04/18/2018 3 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Surface Oncology, Inc.
04/03/2018 4 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Converted 3,184,446 shares @ $0
Converted 83,037 shares @ $0
Bought 94,052 shares @ $12, valued at $1.1M
Converted 3,184,446 preferred shares @ $0
Converted 83,037 preferred shares @ $0
03/28/2018 3 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Unum Therapeutics, Inc.
02/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/01/2017 3 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc.
09/29/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/30/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
07/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2017 4 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Disposed of 700,000 shares @ $0
02/09/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
05/11/2016 4 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Converted 611,827 shares @ $0
Converted 2,463,201 shares @ $0
Converted 862,120 shares @ $0
Converted 492,640 shares @ $0
Converted 946,237 options to buy @ $0
Converted 3,809,524 preferred shares @ $0
Converted 1,333,333 preferred shares @ $0
Converted 761,905 preferred shares @ $0
05/05/2016 3 Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Intellia Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy